Drug-labels.com

Teva-Mycophenolate: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
500 mg, 250 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - Teva-Mycophenolate

Serious Warnings and Precautions Box

  • TEVA-MYCOPHENOLATE can cause first trimester pregnancy loss (miscarriage) and birth defects when used along with other medicines used to prevent organ rejection. You must not take TEVA-MYCOPHENOLATE if you are pregnant. Taking TEVA-MYCOPHENOLATE while pregnant can harm your unborn baby. Women must have two negative pregnancy tests before starting treatment with TEVA-MYCOPHENOLATE. Women must use two reliable forms of contraception at the same time while taking TEVA-MYCOPHENOLATE. See “Other warnings you should know about, Female Patients” for more information.
  • TEVA-MYCOPHENOLATE suppresses your immune system. This can make you more likely to get infections and certain cancers, such as lymphoma.
  • TEVA-MYCOPHENOLATE will be prescribed to you by a doctor with experience in medicines used to prevent organ rejection.

What TEVA-MYCOPHENOLATE is used for:

  • TEVA-MYCOPHENOLATE is used after kidney, heart and liver transplantation to help prevent organ rejection.
  • It is used along with other medicines including cyclosporine and medicines called corticosteroids.

How TEVA-MYCOPHENOLATE works:

TEVA-MYCOPHENOLATE works by slowing down your body's defense system (immune system). When you receive an organ transplant, TEVA-MYCOPHENOLATE prevents your body from rejecting this organ.

The ingredients in TEVA-MYCOPHENOLATE are:

Medicinal ingredient(s): mycophenolate mofetil

Non-medicinal ingredients:

TEVA-MYCOPHENOLATE 250 mg capsules contain the following non-medicinal ingredients: croscarmellose sodium, magnesium stearate, povidone, pregelatinized starch, hard gelatin capsules contain gelatin, titanium dioxide, FD & C Blue 1 (cap) and FD & C Red 40, D & C Red 28, D & C Yellow 10 (body). The compositions of black ink are black iron oxide, propylene glycol and shellac.

TEVA-MYCOPHENOLATE 500 mg tablets contain the following non-medicinal ingredients: croscarmellose sodium, magnesium stearate, microcrystalline cellulose, povidone, opadry coating (hypromellose, polyethylene glycol, talc, titanium dioxide, FD & C Red #40 Allura Red AC Aluminum Lake, FD & C Blue #2 Indigo Carmine Aluminum Lake).

TEVA-MYCOPHENOLATE comes in the following dosage forms:

As capsules containing 250 mg mycophenolate mofetil.

As tablets containing 500 mg mycophenolate mofetil.

Do not use TEVA-MYCOPHENOLATE if:

  • are allergic to mycophenolate mofetil or to mycophenolic acid.
  • are allergic to any other ingredients in TEVA-MYCOPHENOLATE.
  • are pregnant.

  • are breastfeeding.
  • are of childbearing age and not using highly effective birth control.
  • do not have results from a pregnancy test showing that you are not pregnant.

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take TEVA-MYCOPHENOLATE. Talk about any health conditions or problems you may have, including if you:

  • If you are already on any immune suppressant treatment.
  • Rare diseases called Lesch-Nyhan and Kelley-Seegmiller syndrome.
  • Digestive problems, including ones with your stomach or bowels.
  • Severe renal problems.

Other warnings you should know about:

Important warnings for women taking TEVA-MYCOPHENOLATE:

  • Do not take TEVA-MYCOPHENOLATE if you are pregnant.
  • TEVA-MYCOPHENOLATE can cause first trimester pregnancy loss (miscarriage) and birth defects when used along with other medicines used to prevent organ rejection.
  • These birth defects can affect the development of a baby’s ears, limbs, face, heart and brain.
  • You can only take TEVA-MYCOPHENOLATE if you are not pregnant and if you are using highly effective birth control.
  • If you think you may be pregnant tell your doctor right away. Keep taking TEVA-MYCOPHENOLATE until you see your doctor. They will talk to you about other medicines you can take to prevent rejection of your transplanted organ.
  • Women who can get pregnant must have two negative blood or urine pregnancy tests. The second test should be performed 8-10 days after the first. You can only start TEVA-MYCOPHENOLATE if the tests are negative. You will be given repeat pregnancy tests during follow-up visits.
  • You must always use two reliable methods of birth control:

    • Before you start taking TEVA-MYCOPHENOLATE,
    • During your entire treatment with TEVA-MYCOPHENOLATE and
    • For 6 weeks after stopping your treatment with TEVA-MYCOPHENOLATE.
  • Talk to your doctor about the best methods of contraception for you. If you take oral contraceptives (birth control pills) while using TEVA-MYCOPHENOLATE you must also use another form of birth control method. This is because TEVA-MYCOPHENOLATE may make oral contraceptives less effective.
  • Do not breastfeed your baby if you are taking TEVA-MYCOPHENOLATE. It may pass into your breast milk and may harm your baby.
  • Be sure to keep all appointments at your transplant clinic. During these visits, pregnancy tests may be administered by your doctor.

Important warnings for men taking TEVA-MYCOPHENOLATE:

  • If you are a sexually active male, you must use effective birth control. Or, your female partner must use effective birth control while you are taking TEVA-MYCOPHENOLATE. Effective birth control must be used for at least 90 days after you stop taking TEVA-MYCOPHENOLATE.
  • Men should not donate semen during therapy and for 90 days after taking of TEVA-MYCOPHENOLATE.

Serious infections and cancers:

  • TEVA-MYCOPHENOLATE suppresses your immune system. This can make you more likely to get infections and certain cancers, such as lymphoma.
  • TEVA-MYCOPHENOLATE slows down your immune system. This can affect your body’s ability to fight infections. You are more likely to get infections when you take TEVA-MYCOPHENOLATE. Some of these infections can be serious and fatal. Infections include: viral infections, a brain infection called progressive multifocal leukoencephalopathy, sepsis and other infections. It can also cause other infections to emerge in your body like hepatitis B or

    • C or infections caused by polyomaviruses. See “Serious side effects and what to do about them” table for more information.
  • TEVA-MYCOPHENOLATE increases your chances of getting certain cancers, especially skin cancers. See “Serious side effects and what to do about them” table for more information. You must limit the amount of sunlight and UV light you get. Do this by:

    • wearing protective clothing which also covers your head, neck, arms and legs.
    • using a sunscreen with a high sun protection factor (SPF).

Additional Important warnings for all patients taking TEVA-MYCOPHENOLATE:

  • Tell all health professionals you see that you are taking TEVA-MYCOPHENOLATE.
  • Be sure to keep all appointments at your transplant clinic. During these visits, complete blood counts will need to be measured weekly in the first month, twice monthly for the second and third months of treatment and then monthly for the remainder of the first year. Your doctor may sometimes order additional blood tests.
  • You should not donate blood during therapy and for at least 6 weeks after taking TEVA-MYCOPHENOLATE.
  • During treatment with TEVA-MYCOPHENOLATE, vaccinations may be less effective. Also, you should not receive live vaccines. Talk to your doctor before receiving any vaccines.
  • TEVA-MYCOPHENOLATE may affect your ability to drive and use machines. Before driving or using machines, wait until you are feeling well again.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

The following may also interact with TEVA-MYCOPHENOLATE:

  • Acyclovir, an antiviral medication;
  • Ganciclovir or valganciclovir, antiviral medications’
  • Isavuconazole, an antiviral medication;
  • Tacrolimus, used to suppress the body’s immune system;
  • Telmisartan, used to treat high blood pressure;
  • Rifampicin, an antibiotic;
  • Azathioprine, used to suppress the body’s immune system;
  • Antacids, which neutralize stomach acidity;
  • Proton pump inhibitors, such as lansoprazole and pantoprazole;
  • Renagel® (sevelamer), or other calcium free phosphate binders;
  • Cholestyramine, which is used to treat high blood cholesterol.
  • Combinations of antibiotics taken at the same time.

How to take TEVA-MYCOPHENOLATE:

  • Take TEVA-MYCOPHENOLATE exactly as your doctor has told you to. Ask your healthcare professional if you are not sure.
  • Your initial dose of TEVA-MYCOPHENOLATE should be taken as soon as possible following transplantation. If you are not sure of your dose, or when to take it, ask your doctor, pharmacist or nurse.
  • Leave capsules and tablets in blister pack until you are ready to take a dose.
  • Take TEVA-MYCOPHENOLATE on an empty stomach.

  • Swallow tablets or capsules whole with plenty of water. Do not crush, chew or open them up.
  • Space your two doses of TEVA-MYCOPHENOLATE as evenly as you can throughout the day leaving about 12 hours between each dose.
  • Take TEVA-MYCOPHENOLATE along with other medicines prescribed to you, including cyclosporine and medicines called corticosteroids. These are also medicines used to prevent rejection of your transplanted organ. It is important to take all of these medicines properly. Talk to your doctor if you are not sure.
  • Try to take your doses at the same times each day. Taking your medicine at the same time each day will also help you remember each dose.
  • Vomiting or diarrhea may prevent TEVA-MYCOPHENOLATE from being taken up into your body. Always call your doctor if you have either of these episodes.
  • Do not change the dose on your own, no matter how you are feeling. Call your doctor.
  • Do not stop taking TEVA-MYCOPHENOLATE on your own even if you have been taking it for several years.
  • Avoid contact with any powder, including accidentally breathing it in, from damaged capsules or tablets. Wash any powder from your skin with soap and water. If you get any in your eyes, rinse eyes with plain water.

Usual dose:

Kidney Transplant Patients

Adults:

  • A dose of 1 g taken twice a day (daily dose of 2 g) is recommended after kidney transplantation.

Pediatric Patients:

  • Your doctor will decide how much TEVA-MYCOPHENOLATE you will receive. The dose will depend on your body surface area.

Heart Transplant Patients

Adults:

  • A dose of 1.5 g twice a day (daily dose of 3 g) is recommended after heart transplantation in adults.

Liver Transplant Patients

Adults:

  • A dose of 1.5 g taken twice a day (daily dose of 3 g) is recommended after liver transplantation in adults.

Overdose:

If you think you, or a person you are caring for, have taken too much TEVA-MYCOPHENOLATE, contact a healthcare professional, hospital emergency department, regional poison control centre or Health Canada’s toll-free number, 1-844 POISON-X (1-844-764-7669) immediately, even if there are no signs or symptoms.

Missed dose:

  • If you ever do miss a dose of TEVA-MYCOPHENOLATE, do not catch up on your own. Instead call your doctor or pharmacist right away for advice. It is also a good idea to ask your doctor ahead of time what to do about missed doses. Do not double dose.

Possible side effects from using TEVA-MYCOPHENOLATE:

These are not all the possible side effects you may have when taking TEVA-MYCOPHENOLATE. If you experience any side effects not listed here, tell your healthcare professional.

Serious side effects and what to do about them

Symptom/effectTalk to your healthcare professionalStop taking this drug and get immediate medical help
Only if severeIn all cases
VERY COMMON
Abdominal pain√
Blood in urine√
Constipation√
Increased cough√
Diarrhea√
Fever√
Laboured breathing√
Headache√
High blood pressure√
Swelling of parts of your body√
Vomiting√
Weakness√
COMMON
Chest or back pain√
Dizziness√
Heart burn√
Involuntary trembling√
Muscle weakness√
Nausea√
Nosebleed√
Sleeplessness√
Stomach pain√
Sepsis (severe infection): fever and chills, low body temperature, fast heartbeat, nausea and vomiting√
Gastrointestinal perforation (a hole in your stomach or bowels): chills or fever, nausea, severe abdominal pain, vomiting√
UNCOMMON
Blood or black tarry stools√
Joint pain: painful inflammation and stiffness of the joints√
Muscle pain√
UNKNOWN
Progressive multifocal leukoencephalopathy (infection of the brain): loss of coordination, difficulty walking, facial drooping, loss of vision, trouble speaking√
Symptom/effectTalk to your healthcare professionalStop taking this drug and get immediate medical help
Symptom/effectTalk to your healthcare professionalStop taking this drug and get immediate medical help
Only if severeIn all cases
Only if severeIn all cases
Infections: body aches and pains, boils on your skin, chills, cold symptoms, earache, flu-like symptoms, headache, pain when you urinate, sore throat, cuts and scrapes that are red, have pus or don’t heal.
Pure red cell aplasia (bone marrow stops producing red cells): dizziness, fainting, fatigue, feeling unwell, pale skin, pale stools, rapid heartbeat, shortness of breath, weakness√
Neutropenia (decreased white blood cells): infections, fatigue, fever, aches, pains and flu-like symptoms.√
Bone marrow suppression (a large decrease in the production of blood cells and platelets by the bone marrow): fatigue, increased heart rate, unexpected bruising, bleeding; paleness of the skin, lips, and nail beds; dizziness√
BK virus-associated nephropathy (kidney disease due to an infection): changes in vision, like blurred vision; changes in the color of your urine (urine that is brown or red in color); difficulty urinating; needing to urinate more than is normal for you; a cough, cold, or trouble breathing; fever, muscle pain, or weakness.√
Certain types of cancers (such as lymphoma and skin cancer): new moles, skin lesions or bumps; change in the size or colour of a mole, moles with uneven borders√
or that are asymmetric, fever, prolonged tiredness, weight loss, lymph node swelling, a change in your bowel or bladder habits, unusual bleeding or discharge, the appearance of a lump or thickened areas in your breast or anywhere else on your body, unexplained stomach upset or any trouble with swallowing, a nagging cough or hoarseness, night sweats
Anaphylactic Reaction (serious allergic reaction that happens quickly and can be fatal): swelling of the face, lips, tongue, or throat; rash, hives, or itching; fainting, dizziness, feeling lightheaded; trouble breathing or swallowing; fast heartbeat; chest pain√

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, tell your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (canada.ca/drug-device-reporting) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your healthcare professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

  • Keep TEVA-MYCOPHENOLATE out of reach and sight of children. A child who accidentally takes the drug may be seriously harmed. A locked drawer or cupboard is best if you have small children in the house.
  • TEVA-MYCOPHENOLATE capsules should be stored at 15°C - 30°C and the tablets should be stored at 15°C - 25°C. The capsules should be protected from light. The tablets should be protected from light and moisture. Remember to keep each capsule or tablet in its original package until you need to take it.
  • TEVA-MYCOPHENOLATE should not be used after the expiry date (EXP) shown on the package.

If you want more information about TEVA-MYCOPHENOLATE:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); the manufacturer’s website http://www.tevacanada.com; or by calling 1-800-268-4127 ext. 3; or email druginfo@tevacanada.com.

Last Revised: 2026-07-13

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02348675

Revision date stated in the text: July 13, 2026

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Teva-Mycophenolate

Rx or OTC
Prescription (Rx)?
DIN 02348675, 02364883
Schedule(s) PRESCRIPTION
Active ingredient(s) Mycophenolate mofetil
Dosage form(s) Tablet, Capsule
Route(s) of administration Oral
Drug class (WHO ATC)
  1. L Antineoplastic and immunomodulating agents
    1. L04 Immunosuppressants
      1. L04A Immunosuppressants
        1. L04AA Selective immunosuppressants
          1. L04AA06 Mycophenolic acid
Company TEVA CANADA LIMITED
Current status Marketed
Current status date August 8, 2017
Strengths and forms
DIN Strength Dosage form(s) Current status
02348675 500 MG Tablet Marketed August 8, 2017
02364883 250 MG Capsule Marketed August 8, 2017

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.